Net Cash Provided by (Used in) Operating Activities |
-27.8K |
USD |
-237% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
28.1K |
USD |
+241% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
11.2M |
shares |
+15.4% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
283 |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
297 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
2.45M |
USD |
+6.48% |
Q4 2023 |
FY 2023 |
Depreciation |
79 |
USD |
0% |
Q1 2022 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.45M |
USD |
+6.48% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
6.07M |
USD |
+0.87% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
20M |
shares |
|
Q1 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
79 |
USD |
0% |
Q1 2022 |
Q1 2022 |
Interest Expense |
41K |
USD |
+19.7% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |